世界の肝炎検査診断市場インサイト及び予測(酵素免疫測定法(ELISA)、迅速診断検査(RDT)、ポリメラーゼ連鎖反応(PCR)、等温核酸増幅技術(INAAT)、その他)

◆英語タイトル:Global Hepatitis Testing Diagnosis Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09531)◆商品コード:QY22JLX09531
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:126
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、肝炎検査診断のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に肝炎検査診断の世界市場のxxx%を占める「酵素免疫測定法(ELISA)」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
肝炎検査診断の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの肝炎検査診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

肝炎検査診断のグローバル主要企業には、F. Hoffmann-La Roche、Abbott Laboratories、Siemens Healthineers AG、Bio-Rad Laboratories、Danaher Corporation、QIAGEN、BioMerieux SA、DiaSorin S.P.A.、Ortho Clinical Diagnostics、MedMira Inc、Fujirebio、Grifols、Orasure Technologies、GenMark Diagnostics、Vela Diagnostics、Epitope Diagnostics、Trivitron Healthcare、Meril Life Sciences、geneOmbio Technologies、Molbio Diagnosticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

肝炎検査診断市場は、種類と用途によって区分されます。世界の肝炎検査診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
酵素免疫測定法(ELISA)、迅速診断検査(RDT)、ポリメラーゼ連鎖反応(PCR)、等温核酸増幅技術(INAAT)、その他

【用途別セグメント】
病院、血液バンク、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 肝炎検査診断製品概要
- 種類別市場(酵素免疫測定法(ELISA)、迅速診断検査(RDT)、ポリメラーゼ連鎖反応(PCR)、等温核酸増幅技術(INAAT)、その他)
- 用途別市場(病院、血液バンク、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の肝炎検査診断販売量予測2017-2028
- 世界の肝炎検査診断売上予測2017-2028
- 肝炎検査診断の地域別販売量
- 肝炎検査診断の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別肝炎検査診断販売量
- 主要メーカー別肝炎検査診断売上
- 主要メーカー別肝炎検査診断価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(酵素免疫測定法(ELISA)、迅速診断検査(RDT)、ポリメラーゼ連鎖反応(PCR)、等温核酸増幅技術(INAAT)、その他)
- 肝炎検査診断の種類別販売量
- 肝炎検査診断の種類別売上
- 肝炎検査診断の種類別価格
・用途別市場規模(病院、血液バンク、その他)
- 肝炎検査診断の用途別販売量
- 肝炎検査診断の用途別売上
- 肝炎検査診断の用途別価格
・北米市場
- 北米の肝炎検査診断市場規模(種類別、用途別)
- 主要国別の肝炎検査診断市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの肝炎検査診断市場規模(種類別、用途別)
- 主要国別の肝炎検査診断市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の肝炎検査診断市場規模(種類別、用途別)
- 主要国別の肝炎検査診断市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の肝炎検査診断市場規模(種類別、用途別)
- 主要国別の肝炎検査診断市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの肝炎検査診断市場規模(種類別、用途別)
- 主要国別の肝炎検査診断市場規模(トルコ、サウジアラビア)
・企業情報
F. Hoffmann-La Roche、Abbott Laboratories、Siemens Healthineers AG、Bio-Rad Laboratories、Danaher Corporation、QIAGEN、BioMerieux SA、DiaSorin S.P.A.、Ortho Clinical Diagnostics、MedMira Inc、Fujirebio、Grifols、Orasure Technologies、GenMark Diagnostics、Vela Diagnostics、Epitope Diagnostics、Trivitron Healthcare、Meril Life Sciences、geneOmbio Technologies、Molbio Diagnostics
・産業チェーン及び販売チャネル分析
- 肝炎検査診断の産業チェーン分析
- 肝炎検査診断の原材料
- 肝炎検査診断の生産プロセス
- 肝炎検査診断の販売及びマーケティング
- 肝炎検査診断の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 肝炎検査診断の産業動向
- 肝炎検査診断のマーケットドライバー
- 肝炎検査診断の課題
- 肝炎検査診断の阻害要因
・主な調査結果

The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis
Common hepatitis tests include Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), etc.
Market Analysis and Insights: Global Hepatitis Testing Diagnosis Market
Due to the COVID-19 pandemic, the global Hepatitis Testing Diagnosis market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Enzyme-linked Immunosorbent Assay (ELISA) accounting for % of the Hepatitis Testing Diagnosis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Hepatitis Testing Diagnosis market size is valued at US$ million in 2021, while the US and Europe Hepatitis Testing Diagnosis are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hepatitis Testing Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Hepatitis Testing Diagnosis include F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, Bio-Rad Laboratories, Danaher Corporation, QIAGEN, BioMerieux SA, DiaSorin S.P.A. and Ortho Clinical Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Hepatitis Testing Diagnosis Scope and Segment
Hepatitis Testing Diagnosis market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hepatitis Testing Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Segment by Application
Hospital
Blood Banks
Other
By Company
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Hepatitis Testing Diagnosis Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis Testing Diagnosis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Enzyme-linked Immunosorbent Assay (ELISA)
1.2.3 Rapid Diagnostic Tests (RDT)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hepatitis Testing Diagnosis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Blood Banks
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis Testing Diagnosis Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis Testing Diagnosis Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis Testing Diagnosis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis Testing Diagnosis Sales by Region
2.4.1 Global Hepatitis Testing Diagnosis Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis Testing Diagnosis by Region (2023-2028)
2.5 Global Hepatitis Testing Diagnosis Revenue by Region
2.5.1 Global Hepatitis Testing Diagnosis Revenue by Region (2017-2022)
2.5.2 Global Hepatitis Testing Diagnosis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis Testing Diagnosis Sales by Manufacturers
3.1.1 Global Top Hepatitis Testing Diagnosis Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis Testing Diagnosis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis Testing Diagnosis in 2021
3.2 Global Hepatitis Testing Diagnosis Revenue by Manufacturers
3.2.1 Global Hepatitis Testing Diagnosis Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis Testing Diagnosis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis Testing Diagnosis Revenue in 2021
3.3 Global Hepatitis Testing Diagnosis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis Testing Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis Testing Diagnosis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis Testing Diagnosis Sales by Type
4.1.1 Global Hepatitis Testing Diagnosis Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis Testing Diagnosis Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis Testing Diagnosis Revenue by Type
4.2.1 Global Hepatitis Testing Diagnosis Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis Testing Diagnosis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis Testing Diagnosis Price by Type
4.3.1 Global Hepatitis Testing Diagnosis Price by Type (2017-2022)
4.3.2 Global Hepatitis Testing Diagnosis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis Testing Diagnosis Sales by Application
5.1.1 Global Hepatitis Testing Diagnosis Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis Testing Diagnosis Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis Testing Diagnosis Revenue by Application
5.2.1 Global Hepatitis Testing Diagnosis Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis Testing Diagnosis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis Testing Diagnosis Price by Application
5.3.1 Global Hepatitis Testing Diagnosis Price by Application (2017-2022)
5.3.2 Global Hepatitis Testing Diagnosis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis Testing Diagnosis Market Size by Type
6.1.1 North America Hepatitis Testing Diagnosis Sales by Type (2017-2028)
6.1.2 North America Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
6.2 North America Hepatitis Testing Diagnosis Market Size by Application
6.2.1 North America Hepatitis Testing Diagnosis Sales by Application (2017-2028)
6.2.2 North America Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
6.3 North America Hepatitis Testing Diagnosis Market Size by Country
6.3.1 North America Hepatitis Testing Diagnosis Sales by Country (2017-2028)
6.3.2 North America Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis Testing Diagnosis Market Size by Type
7.1.1 Europe Hepatitis Testing Diagnosis Sales by Type (2017-2028)
7.1.2 Europe Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
7.2 Europe Hepatitis Testing Diagnosis Market Size by Application
7.2.1 Europe Hepatitis Testing Diagnosis Sales by Application (2017-2028)
7.2.2 Europe Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
7.3 Europe Hepatitis Testing Diagnosis Market Size by Country
7.3.1 Europe Hepatitis Testing Diagnosis Sales by Country (2017-2028)
7.3.2 Europe Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis Testing Diagnosis Market Size by Type
8.1.1 Asia Pacific Hepatitis Testing Diagnosis Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis Testing Diagnosis Market Size by Application
8.2.1 Asia Pacific Hepatitis Testing Diagnosis Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis Testing Diagnosis Market Size by Region
8.3.1 Asia Pacific Hepatitis Testing Diagnosis Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis Testing Diagnosis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hepatitis Testing Diagnosis Market Size by Type
9.1.1 Latin America Hepatitis Testing Diagnosis Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
9.2 Latin America Hepatitis Testing Diagnosis Market Size by Application
9.2.1 Latin America Hepatitis Testing Diagnosis Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
9.3 Latin America Hepatitis Testing Diagnosis Market Size by Country
9.3.1 Latin America Hepatitis Testing Diagnosis Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis Testing Diagnosis Market Size by Type
10.1.1 Middle East and Africa Hepatitis Testing Diagnosis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis Testing Diagnosis Market Size by Application
10.2.1 Middle East and Africa Hepatitis Testing Diagnosis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis Testing Diagnosis Market Size by Country
10.3.1 Middle East and Africa Hepatitis Testing Diagnosis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 F. Hoffmann-La Roche Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Corporation Information
11.3.2 Siemens Healthineers AG Overview
11.3.3 Siemens Healthineers AG Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Siemens Healthineers AG Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Siemens Healthineers AG Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Corporation Information
11.4.2 Bio-Rad Laboratories Overview
11.4.3 Bio-Rad Laboratories Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio-Rad Laboratories Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio-Rad Laboratories Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Corporation Information
11.5.2 Danaher Corporation Overview
11.5.3 Danaher Corporation Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Danaher Corporation Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Danaher Corporation Recent Developments
11.6 QIAGEN
11.6.1 QIAGEN Corporation Information
11.6.2 QIAGEN Overview
11.6.3 QIAGEN Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 QIAGEN Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 QIAGEN Recent Developments
11.7 BioMerieux SA
11.7.1 BioMerieux SA Corporation Information
11.7.2 BioMerieux SA Overview
11.7.3 BioMerieux SA Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BioMerieux SA Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioMerieux SA Recent Developments
11.8 DiaSorin S.P.A.
11.8.1 DiaSorin S.P.A. Corporation Information
11.8.2 DiaSorin S.P.A. Overview
11.8.3 DiaSorin S.P.A. Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 DiaSorin S.P.A. Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 DiaSorin S.P.A. Recent Developments
11.9 Ortho Clinical Diagnostics
11.9.1 Ortho Clinical Diagnostics Corporation Information
11.9.2 Ortho Clinical Diagnostics Overview
11.9.3 Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ortho Clinical Diagnostics Recent Developments
11.10 MedMira Inc
11.10.1 MedMira Inc Corporation Information
11.10.2 MedMira Inc Overview
11.10.3 MedMira Inc Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 MedMira Inc Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MedMira Inc Recent Developments
11.11 Fujirebio
11.11.1 Fujirebio Corporation Information
11.11.2 Fujirebio Overview
11.11.3 Fujirebio Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Fujirebio Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fujirebio Recent Developments
11.12 Grifols
11.12.1 Grifols Corporation Information
11.12.2 Grifols Overview
11.12.3 Grifols Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Grifols Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Grifols Recent Developments
11.13 Orasure Technologies
11.13.1 Orasure Technologies Corporation Information
11.13.2 Orasure Technologies Overview
11.13.3 Orasure Technologies Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Orasure Technologies Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Orasure Technologies Recent Developments
11.14 GenMark Diagnostics
11.14.1 GenMark Diagnostics Corporation Information
11.14.2 GenMark Diagnostics Overview
11.14.3 GenMark Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 GenMark Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 GenMark Diagnostics Recent Developments
11.15 Vela Diagnostics
11.15.1 Vela Diagnostics Corporation Information
11.15.2 Vela Diagnostics Overview
11.15.3 Vela Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Vela Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Vela Diagnostics Recent Developments
11.16 Epitope Diagnostics
11.16.1 Epitope Diagnostics Corporation Information
11.16.2 Epitope Diagnostics Overview
11.16.3 Epitope Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Epitope Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Epitope Diagnostics Recent Developments
11.17 Trivitron Healthcare
11.17.1 Trivitron Healthcare Corporation Information
11.17.2 Trivitron Healthcare Overview
11.17.3 Trivitron Healthcare Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Trivitron Healthcare Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Trivitron Healthcare Recent Developments
11.18 Meril Life Sciences
11.18.1 Meril Life Sciences Corporation Information
11.18.2 Meril Life Sciences Overview
11.18.3 Meril Life Sciences Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Meril Life Sciences Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Meril Life Sciences Recent Developments
11.19 geneOmbio Technologies
11.19.1 geneOmbio Technologies Corporation Information
11.19.2 geneOmbio Technologies Overview
11.19.3 geneOmbio Technologies Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 geneOmbio Technologies Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 geneOmbio Technologies Recent Developments
11.20 Molbio Diagnostics
11.20.1 Molbio Diagnostics Corporation Information
11.20.2 Molbio Diagnostics Overview
11.20.3 Molbio Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Molbio Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Molbio Diagnostics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis Testing Diagnosis Industry Chain Analysis
12.2 Hepatitis Testing Diagnosis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis Testing Diagnosis Production Mode & Process
12.4 Hepatitis Testing Diagnosis Sales and Marketing
12.4.1 Hepatitis Testing Diagnosis Sales Channels
12.4.2 Hepatitis Testing Diagnosis Distributors
12.5 Hepatitis Testing Diagnosis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis Testing Diagnosis Industry Trends
13.2 Hepatitis Testing Diagnosis Market Drivers
13.3 Hepatitis Testing Diagnosis Market Challenges
13.4 Hepatitis Testing Diagnosis Market Restraints
14 Key Findings in The Global Hepatitis Testing Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肝炎検査診断市場インサイト及び予測(酵素免疫測定法(ELISA)、迅速診断検査(RDT)、ポリメラーゼ連鎖反応(PCR)、等温核酸増幅技術(INAAT)、その他)(Global Hepatitis Testing Diagnosis Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。